HB0776 is a broad update to Maryland’s Medical Practice Act and Physician Assistants Act. The bill cleans up obsolete and redundant language, standardizes terminology across the State Board of Physicians’ statutes, and makes a series of technical and substantive changes affecting physicians, physician assistants, and several allied health professions regulated by the Board. It revises licensure, renewal, reinstatement, and exemption provisions; updates definitions; and expands or clarifies the Board’s authority over investigations, discipline, reporting, and public disclosure.
A major theme of the bill is aligning the rules for multiple licensed professions under the Board, including respiratory care, radiologic and nuclear medicine professions, polysomnography, athletic training, perfusion, naturopathic medicine, genetic counseling, and physician assistants. For many of these professions, the bill renames advisory bodies as advisory committees, sets membership requirements, term limits, residency and good-standing requirements, and quorums, and gives the Board more flexibility to adopt regulations governing committee operations. It also updates federal-government practice exemptions, clarifies collaboration or supervision requirements in some professions, and revises the conditions under which unlicensed practice or employment of unlicensed individuals is prohibited.
The bill also strengthens oversight and enforcement. It authorizes the Board to impose administrative penalties in certain situations, increases some civil penalties, expands grounds for discipline, and adds or revises reporting obligations for employers, hospitals, related institutions, and alternative health systems when a licensee’s privileges or employment are restricted or terminated for potentially disciplinary reasons. It also expands public-facing disclosure requirements, including posting charges and certain disciplinary information on the Board’s website, while maintaining confidentiality for some records and reports. In addition, it adjusts fee and fund provisions so Board-collected fees support regulatory duties and, in some circumstances, the Maryland Loan Assistance Repayment Program for Physicians and Physician Assistants.
The overall sentiment reflected by the bill text is regulatory and administrative rather than ideological: it appears designed to modernize and harmonize professional licensing law, improve patient-safety oversight, and give the Board clearer tools for enforcement and public transparency. Because no committee transcripts or recorded votes were provided, there is no documented floor or committee debate to indicate broader political support or opposition in the available materials.
The most notable points of contention embedded in the bill are the expanded reporting duties, the increased civil and administrative penalties, and the broader disciplinary and disclosure powers given to the Board. Those provisions affect employers, hospitals, and licensees by requiring more detailed reporting, allowing penalties for bad-faith or non-reporting conduct, and making more disciplinary information public. Another potentially sensitive area is the bill’s treatment of substance-use-related impairment, which preserves certain confidentiality protections while still requiring reporting in some circumstances. The bill also imposes new collaboration requirements for naturopathic doctors and updates supervision and practice restrictions across several professions, which could be significant for practitioners and employers subject to the Board’s rules.
HB0776 amends numerous sections of the Health Occupations Article, primarily Titles 14 and 15, to update the State Board of Physicians’ authority and the licensing/disciplinary framework for physicians, physician assistants, and allied health professionals. It repeals obsolete provisions, revises definitions, changes renewal and reinstatement procedures, expands reporting and disclosure obligations, and increases or adds civil and administrative penalties. It also creates or revises provisions governing advisory committees, employer reporting, public licensee profiles, and collaboration or supervision requirements, while directing collected fees and penalties into the Board of Physicians Fund or the General Fund as specified.
The bill appears generally favorable toward regulatory modernization and patient-safety oversight, with a strong emphasis on consistency, transparency, and enforcement. In the absence of committee testimony or vote data, there is no recorded evidence of partisan or stakeholder opposition in the provided materials. The structure of the bill suggests an administrative cleanup measure with substantive enforcement enhancements rather than a controversial policy overhaul.
The main areas likely to draw concern are the expanded mandatory reporting requirements for employers and health care entities, the increased penalties for failure to report or for bad-faith reporting, and the broader public disclosure of charges and disciplinary actions. Licensees and employers may view these provisions as increasing compliance burdens and exposure to sanctions, while the Board and patient-safety advocates would likely see them as necessary oversight tools. Additional tension may arise around the bill’s new collaboration requirement for naturopathic doctors and the stricter supervision/employment rules for unlicensed practice across multiple professions.